Tumor necrosis factor is increased in the spinal cord of an animal model of motor neuron degeneration

European Cytokine Network

Volumn 9, Issue 2, 1998, Pages 139-144

  Ghezzi, Pietro ^a   Bernardini, Renato ^b   Giuffrida, Rosario ^b   Bellomo, Maria ^b   Manzoni, Cristina ^a   Comoletti, Daniele ^a   Di Santo, Elena ^a   Benigni, Fabio ^a   Mennini, Tiziana ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

mnd mice; Motor neuron disease; Spinal cord; TNF

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MOTONEURON; MOTOR NEURON DISEASE; MOUSE; NONHUMAN; SERUM; SPINAL CORD; SPINAL CORD VENTRAL HORN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, NEUROLOGIC MUTANTS; MOTOR NEURONS; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0031841018     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Appel S H, Smith R G, Engelhardt J I, Stefani E. 1993. Evidence for autoimmunity in amyotrophic lateral sclerosis. (Review) J. Neurol. Sci. 118: 169.
2. Engelhardt J I, Appel S H, Killian J M. 1989. Experimental autoimmune motor neuron disease. Ann. Neurol. 26: 368.
3. Engelhardt J I, Appel S H, Killian J M. 1990. Motor neuron destruction in guinea pigs immunized with bovine spinal cord ventral horn homogenate: experimental autoimmune gray matter disease. J. Neuroimmunol 27: 21.
4. Plaitakis A, Constantakakis E, Smith J. 1988. The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis. Ann. Neurol. 24: 446.
5. Rothstein J D. 1995. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. (Review) Adv. Neurol. 68: 7.
6. Bensimon G, Lacomblez L, Meininger V. 1994. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/riluzole Study Group N. Engl. J. Med. 330: 585.
7. Sharief M K, Hentges R. 1991. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 325: 467.
8. Ruddle N H, Bergman C M, McGrath K M, Lingenheld E G, Grunnet M L, Padula S J, Clark R B. 1990. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172: 1193.
9. Baker D, Butler D, Scallon BJ, O'Neill J K, Turk J L, Feldmann M. 1994. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24: 2040.
10. Meistrell III ML, Cockroft K M, Botchkina G I, Di Santo E, Bloom O, Vishnubhakat J, Ulrich P, Ghezzi P, Tracey K. 1997. TNF mediates brain damage in stroke. Stroke 28: 255.
11. Minami M, Kuraishi Y, Satoh M. 1991. Effects of kainic acid on messenger RNA levels of IL-1beta, IL-6, TNF-alpha and LIF in the rat brain. Biochem. Biophys. Res. Commun. 176: 593.
12. Chao C C, Hu S. 1994. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev. Neurosci. 16: 172.
13. Messer A. 1994. Mutant mouse models of ALS. Neurobiol. Aging 15: 247.
14. Callahan L M, Wylen E L, Messer A, Mazurkiewicz J E. 1991. Neurofilament distribution is altered in the mnd (motor neuron degeneration) mouse. J. Neuropathol. Exp. Neurol. 50: 491.
15. Pardo C A, Rabin B A, Palmer D N, Price D L. 1994. Accumulation of the adenosine triphosphate synthase subunit C in the mnd mutant mouse. A model for neuronal ceroid lipofuscinosis. Am. J. Pathol. 144: 829.
16. Messer A, Strominger N L, Mazurkiewicz J E. 1987. Histopathology of the late-onset motor neuron degeneration (mnd) mutant in the mouse. J. Neurogenet. 4: 201.
17. Comoletti D, Bastone A, Crespi D, Manzoni C, Mennini T. 1997. Alterations in blood glutamic acid concentrations and spinal cord GLT-1 glutamate transporter in motor neuron degeneration (mnd) mice. Eur. Neuropsychopharm. 7, S2: S293.
18. Mennini T, Bastone A, Crespi D, Comoletti D, Manzoni C. 1998. Spinal cord GLT-1 glutamate transporter and blood glutamic acid alterations in motor neuron degeneration (mnd) mice. J. Neurol. Sci. 157: 31.
19. Bakalian A, Kopmels B, Messer A, Fradelizi D, Delhaye-Bouchaud N, Wollman E, Mariani J. 1992. Peripheral macrophage abnormalities in mutant mice with spinocerebellar degeneration. Res. Immunol. 143: 129.
20. Glabinski A, Mirecka M, Pokoca L. 1995. Tumor necrosis factor alpha but not lymphotoxin is overproduced by blood mononuclear cells in multiple sclerosis. Acta Neurol. Scand. 91: 276.
21. Chofflon M, Juillard C, Juillard P, Gauthier G, Grau G E. 1992. Tumor necrosis factor-α production as a possible predictor of relapse in patients with multiple sclerosis. Eur. Cytokine Netw: 3: 523.
22. Aggarwal B B, Khor W J, Hass P E, Moffat B, Spencer S A, Henzel J, Bringman S, Nedwin G E, Goeddel D V, Harkins R N. 1985. Human tumor necrosis factor. Production, purification and characterization. J. Biol. Chem. 260: 2345.
23. Renno T, Krakowski M, Piccirillo C, Lin J Y, Owens T. 1995. TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J. Immunol. 154: 944.
24. Liu T, Clark R K, McDonnel P C, Young P R, White R F, Barone F C, Feuerstein G Z. 1994. Tumor necrosis factor-α expression in ischemic neurons. Stroke 25: 1481.
25. Bruce A J, Boling W, Kindy M S, Peschon J, Kraemer P J, Carpenter M K, Holtsberg F W, Mattson M P. 1996. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med. 2: 788.
26. Sommer N, Löschmann P A, Northoff G H, Weller M, Steinbrecher A, Steinbach J P, Lichtenfels R, Meyermann R, Riethmüller A, Fontana A, Dichgans J, Martin R. 1995. The anti-depressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nature Med. 1: 244.
27. Martiney J, Rajan A, Cerami A, Tracey K J, Brosnan C F. 1996. Suppression of acute experimental encephalitis by CNI-1493, an inhibitor of TNF synthesis. J. Invest. Med. 44: 200.
28. Helgren M E, Squinto S P, Davis H L, Parry D J, Boulton T G, Heck C S, Zhu Y, Yancopoulos G D, Lindsay R M, Di Stefano PS. 1994. Trophic effect of ciliary neurotrophic factor on denervated skeletal muscle. Cell 76: 493.
29. Mitsumoto H, Ikeda K, Klinkosz B, Cedarbaum J M, Wong V, Lindsay R M. 1994. Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science 265: 1107.
30. DeChiara T M, Vejsada R, Poueymirou W T, Acheson A, Suri C, Conover J C, Friedman B, McClain J, Pan L, Stahl N, Ip N Y, Kato A, Yancopoulos G D. 1995. Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficit at birth. Cell 83: 313.
31. Benigni F, Villa P, Demitri M T, Sacco S, Sipe J D, Lagunowich L, Panayotatos N, Ghezzi P. 1995. Ciliary neurotrophic factor inhibits brain and peripheral TNF production and, when coadministered with its soluble receptor, protects mice against LPS toxicity. Mol. Med. 1: 568.
32. Ikeda K, Kinoshita M, Tagaya N, Shiojima T, Taga T, Yakusawa K, Suzuki H, Okano A. 1996. Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease. Brain Res. 726: 91.
33. Aderka D, Le J M, Vilcek J. 1989. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes. U937 cells, and in mice. J. Immunol 143: 3517.
34. Schubert D, Kimura H, Maher P. 1992. Growth factors and vitamin E modify neuronal glutamate toxicity. Proc. Natl. Acad. Sci. USA 89: 8264.
35. Wiedau-Pazos M, Goto J J, Rabizadeh S, Gralla E B, Roe J A, Lee M K, Valentine J S, Bredesen D E. 1996. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271: 515.
36. Gurney M E, Pu H, Chiu A Y, Dal Canto M, Polchow C Y, Alexander D D, Caliendo J, Hentati A, Kwon Y W, Deng H X, Chen W, Zhai P, Sufit R L, Siddique T. 1994. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264: 1772.
37. Henderson J T, Javaheri M, Kopko S, Roder J C. 1996. Reduction of lower motor neuron degeneration in wobbler mice by N-acetyl-L-cysteine. J. Neurosci. 16: 7574.
38. Gurney M E, Cutting F B, Zhai P, Dohle A, Taylor C P, Andrus P K, Hall E D. 1996. Benefit of vitamin E, riluzole, and gahapentin in a transgenic model of familiar amyotrophic lateral sclerosis. Ann. Neurol. 39: 147.
39. Schulze-Osthoff K, Bakker A C, Vanhaesenbroeck B, Beyaert R, Jacob W A, Fiers W. 1992. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial function. Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267: 5317.
40. Peristeris P, Clark B D, Gatti S, Faggioni R, Mantovani A, Mengozzi M, Orencole S F, Sironi M, Ghezzi P. 1992. N-acetyl-cysteine and glutathione as inhibitors of tumor necrosis factor production. Cell. Immunol. 140: 390.